RAPT Therapeutics (RAPT) Other Accumulated Expenses: 2020-2024
Historic Other Accumulated Expenses for Therapeutics (RAPT) over the last 5 years, with Sep 2024 value amounting to $168,000.
- Therapeutics' Other Accumulated Expenses rose 7.69% to $168,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $168,000, marking a year-over-year increase of 7.69%. This contributed to the annual value of $178,000 for FY2023, which is 25.21% down from last year.
- Therapeutics' Other Accumulated Expenses amounted to $168,000 in Q3 2024, which was up 33.33% from $126,000 recorded in Q2 2024.
- Over the past 5 years, Therapeutics' Other Accumulated Expenses peaked at $436,000 during Q1 2020, and registered a low of $117,000 during Q1 2022.
- Over the past 3 years, Therapeutics' median Other Accumulated Expenses value was $173,000 (recorded in 2022), while the average stood at $173,364.
- In the last 5 years, Therapeutics' Other Accumulated Expenses plummeted by 65.38% in 2022 and then skyrocketed by 101.71% in 2023.
- Over the past 5 years, Therapeutics' Other Accumulated Expenses (Quarterly) stood at $328,000 in 2020, then fell by 22.56% to $254,000 in 2021, then fell by 6.30% to $238,000 in 2022, then decreased by 25.21% to $178,000 in 2023, then climbed by 7.69% to $168,000 in 2024.
- Its last three reported values are $168,000 in Q3 2024, $126,000 for Q2 2024, and $203,000 during Q1 2024.